North America Doxorubicin Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Drug Formulation (Lyophilized Powder and Doxorubicin Injection), Application (Breast Cancer, Kidney Cancer, Liver Cancer, Sarcoma, Ovarian Cancer, Lung Cancer, Leukemia, Multiple Myeloma, and Others), and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) 

No. of Pages: 140    |    Report Code: BMIRE00027268    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Doxorubicin Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Doxorubicin Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Doxorubicin Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increasing Prevalence of Cancer
  • 5.1.2 Increasing Preference for Chemotherapy
5.2 Market Opportunities
  • 5.2.1 Increasing Government Funding and Grants
5.3 Future Trends
  • 5.3.1 Introduction of Nanaomaterials in Cancer Treatment is the New Trends Witnessed in the Market
5.4 Impact of Drivers and Restraints

6. North America Doxorubicin Market Regional Analysis

6.1 North America Doxorubicin Market Overview
6.2 North America Doxorubicin Market Revenue 2020-2028 (US$ Million)
6.3 North America Doxorubicin Market Forecast Analysis

7. North America Doxorubicin Market Analysis – by Drug Formulation

7.1 Lyophilized Powder
  • 7.1.1 Overview
  • 7.1.2 Lyophilized Powder: North America Doxorubicin Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Doxorubicin Injection
  • 7.2.1 Overview
  • 7.2.2 Doxorubicin Injection: North America Doxorubicin Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Doxorubicin Market Analysis – by Application

8.1 Breast Cancer
  • 8.1.1 Overview
  • 8.1.2 Breast Cancer: North America Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Kidney Cancer
  • 8.2.1 Overview
  • 8.2.2 Kidney Cancer: North America Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Liver Cancer
  • 8.3.1 Overview
  • 8.3.2 Liver Cancer: North America Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Sarcoma
  • 8.4.1 Overview
  • 8.4.2 Sarcoma: North America Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Ovarian Cancer
  • 8.5.1 Overview
  • 8.5.2 Ovarian Cancer: North America Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Lung Cancer
  • 8.6.1 Overview
  • 8.6.2 Lung Cancer: North America Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Leukemia
  • 8.7.1 Overview
  • 8.7.2 Leukemia: North America Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
8.8 Multiple Myeloma
  • 8.8.1 Overview
  • 8.8.2 Multiple Myeloma: North America Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

9. North America Doxorubicin Market Analysis – by Distribution Channel

9.1 Hospital Pharmacy
  • 9.1.1 Overview
  • 9.1.2 Multiple Myeloma: North America Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Retail Pharmacy
  • 9.2.1 Overview
  • 9.2.2 Multiple Myeloma: North America Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Online Pharmacy
  • 9.3.1 Overview
  • 9.3.2 Multiple Myeloma: North America Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

10. North America Doxorubicin Market – North America Analysis

10.1 North America
  • 10.1.1 North America Doxorubicin Market Breakdown, by Key Country, 2023 and 2028 (%)
  • 10.1.1.1 North America Doxorubicin Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 US: North America Doxorubicin Market Breakdown, by Drug Formulation
    • 10.1.1.1.2 US: North America Doxorubicin Market Breakdown, by Application
    • 10.1.1.1.3 US: North America Doxorubicin Market Breakdown, by Distribution Channel
  • 10.1.1.2 Canada: North America Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Canada: North America Doxorubicin Market Breakdown, by Drug Formulation
    • 10.1.1.2.2 Canada: North America Doxorubicin Market Breakdown, by Application
    • 10.1.1.2.3 Canada: North America Doxorubicin Market Breakdown, by Distribution Channel
  • 10.1.1.3 Mexico : North America Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 Mexico : North America Doxorubicin Market Breakdown, by Drug Formulation
    • 10.1.1.3.2 Mexico : North America Doxorubicin Market Breakdown, by Application
    • 10.1.1.3.3 Mexico : North America Doxorubicin Market Breakdown, by Distribution Channel

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America Doxorubicin Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Accord Healthcare
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Baxter International Inc.
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Cipla Inc.
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Dr. Reddy's Laboratories
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Janssen Pharmaceuticals (Johnson & Johnson Services, Inc.)
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Meiji Holdings Co., Ltd.
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Novartis AG
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Pfizer Inc.
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Sun Pharmaceutical Industries Ltd
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Zydus Cadila
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - North America Doxorubicin Market

  1. Accord Healthcare
  2. Baxter International Inc.
  3. Cipla Inc.
  4. Dr. Reddy's Laboratories
  5. Janssen Pharmaceuticals (Johnson & Johnson Services, Inc.)
  6. Meiji Holdings Co., Ltd.
  7. Novartis AG
  8. Pfizer Inc. 
  9. Sun Pharmaceutical Industries Ltd
  10. Zydus Cadila
north-america-doxorubicin-market